News
Absci Corporation stock has dropped since January, driven by weak earnings and broader biotech sector pressures. Learn more ...
As part of this partnership, AMD made a $20 million strategic investment in Absci. This collaboration supports our mission of creating better biologics faster by offering optimized compute ...
Vancouver-based Absci to send first drug to clinical trials in what CEO calls a ‘huge milestone’
Absci is preparing to send its first internally ... The company also announced a collaboration with chipmaker AMD to power its advanced de novo AI antibody design models, as well as AI ...
7 analysts have expressed a variety of opinions on Absci ABSI over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ...
Absci Corp's collaboration with AMD provides optimized compute solutions, enhancing performance and reducing costs for complex biological modeling. The company demonstrated significant ...
Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results
VANCOUVER, Wash. and NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today reported financial and operating results ...
Shares of Absci Corporation ABSI fell sharply in today's pre-market trading after the company reported worse-than-expected fourth-quarter financial results. Absci reported quarterly losses of 25 ...
16:31 EDT Absci (ABSI) files to sell 5.71M shares of common stock for holders Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.
(MENAFN- GlobeNewsWire - Nasdaq) VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today ...
Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results
Unveiled updates across proprietary pipeline and demonstrated new breakthroughs by AI platform at 2024 R&D Day Entered into collaboration with AMD ... investment in Absci Achieved 2024 outlook ...
Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results
Achieved 2024 outlook for drug creation partnerships through collaborations with Owkin, Twist Bioscience, Invetx, and Memorial Sloan Kettering Cancer Center Absci continues to focus its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results